No Data
No Data
Zimmer Biomet Holdings: Strategic Product Launches and Favorable Valuation Drive Buy Rating
Should You Think About Buying Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Now?
CCORF Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Maintains Target Price $115
SA Asks: What's the Most Attractive Medtech Stock Right Now?
Sector Update: Health Care Stocks Lower in Afternoon Trading
Fund Update: Boston Trust Walden Corp Opened a $54.1M Position in $ZBH Stock